Research and Clinical Trials
Search Cancer Clinical Trials
Clinical Trials
New Search
| Title | Pemetrexed and Carboplatin in Recurrent Platinum Sensitive Ovarian Cancer |
|---|---|
| Disease/Condition | Ovarian Cancer |
| Description | The purpose of this study is to determine the effects (good and bad) the combination of carboplatin and pemetrexed has on patients with recurrent ovarian, peritoneal, or fallopian tube cancer. |
| Eligibility Criteria | To be eligible for this study, patients must meet several criteria, including but not limited to the following: * Patient must be Female and 18 years or older * Patient must have a histopathologically confirmed diagnosis of epithelial ovarian, primary peritoneal, or fallopian tube carcinoma. * Patient must have a life expectancy of greater than 12 weeks. |
| Principal Investigator | Dennis Kuo, MD |
| Contact Name | Loraine Centrilla, RN |
| Phone | (718) 405-8200 |
| Contact Email | lcentril@montefiore.org |
| Post Date | 10/29/2006 |
| Protocol Number | 08-04-097/West |
| Status | Recruiting |
| Current Trial Type | Interventional |
